Skip to main content
Log in

Comprehensive surveillance of adverse drug reactions in hospital provides important data to inform the safe use of drug therapy

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. World Health Organization. International drug monitoring: the role of the hospital. WHO Tech Rep Ser 1969; No. 425

  2. Thürmann PA. Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 2001; 24(13): 961–8

    Article  PubMed  Google Scholar 

  3. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9

    Article  CAS  PubMed  Google Scholar 

  4. Evans JMM, MacDonald TM. Record-linkage for pharmacovigilance in Scotland. Br J Clin Pharmacol 1999; 47: 105–10

    Article  CAS  PubMed  Google Scholar 

  5. Currie CJ, MacDonald TM. Use of routine healthcare data in safe and cost-effective drug use. Drug Saf 2000; 22: 97–102

    Article  CAS  PubMed  Google Scholar 

  6. Lau HS, Florax C, Porsius AJ, et al. The completeness of medication histories in hospital medical reports of patients admitted to general internal medicine wards. Br J Clin Pharmacol 2000; 49: 597–603

    Article  CAS  PubMed  Google Scholar 

  7. Schmitt K, Windecker R, Steffen J, et al. Detection of adverse drug reactions by a computer-based generation of laboratory signals [abstract]. Br J Clin Pharmacol 2000 [Abstracts of CPT 2000]; 87: A331

    Google Scholar 

  8. Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301–8

    Article  CAS  PubMed  Google Scholar 

  9. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61–8

    Article  CAS  PubMed  Google Scholar 

  10. Pouyanne P, Haramburu F, Imbs JL, et al., for the French Pharmacovigilance Centres. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 2000; 320: 1036

    Article  CAS  PubMed  Google Scholar 

  11. Roughead EE, Gilbert AL, Primrose JG, et al. Drug-related hospital admissions: a review of Australian studies published 1988–1996. Med J Aust 1998; 168: 405–8

    CAS  PubMed  Google Scholar 

  12. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279: 1200–7

    Article  CAS  PubMed  Google Scholar 

  13. Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring — cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admission. Pharmacoepidemiol Drug Saf 1997; 6 (3 Suppl.): S71–7

    Article  PubMed  Google Scholar 

  14. Imbs JL, Pouyanne P, Haramburu F, et al. Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Thérapie 1999; 54: 21–7

    CAS  PubMed  Google Scholar 

  15. Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation. Drug Saf 2000; 2: 161–8

    Article  Google Scholar 

  16. Hallas J, Harvald B, Worm J, et al. Drug related hospital admissions. Eur J Clin Pharmacol 1993; 45: 199–203

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Comprehensive surveillance of adverse drug reactions in hospital provides important data to inform the safe use of drug therapy. Drugs Ther. Perspect 18, 14–16 (2002). https://doi.org/10.2165/00042310-200218120-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218120-00005

Keywords

Navigation